These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1091 related items for PubMed ID: 17136752

  • 1. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH, Avorn J, Katz JN, Weinblatt ME, Setoguchi S, Levin R, Schneeweiss S.
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [Abstract] [Full Text] [Related]

  • 2. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
    van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE.
    Arthritis Res Ther; 2006 Dec; 8(5):R151. PubMed ID: 16984661
    [Abstract] [Full Text] [Related]

  • 3. Antirheumatic drug use and the risk of acute myocardial infarction.
    Suissa S, Bernatsky S, Hudson M.
    Arthritis Rheum; 2006 Aug 15; 55(4):531-6. PubMed ID: 16874796
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis.
    Wolfe F, Michaud K.
    Arthritis Rheum; 2008 Sep 15; 58(9):2612-21. PubMed ID: 18759273
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
    Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S.
    Arthritis Rheum; 2006 May 15; 54(5):1378-89. PubMed ID: 16645966
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Patterns of cardiovascular risk in rheumatoid arthritis.
    Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S, Canning C, Schneeweiss S.
    Ann Rheum Dis; 2006 Dec 15; 65(12):1608-12. PubMed ID: 16793844
    [Abstract] [Full Text] [Related]

  • 11. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis.
    Van Doornum S, Brand C, King B, Sundararajan V.
    Arthritis Rheum; 2006 Jul 15; 54(7):2061-8. PubMed ID: 16802340
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
    Wållberg-Jonsson S, Johansson H, Ohman ML, Rantapää-Dahlqvist S.
    J Rheumatol; 1999 Dec 15; 26(12):2562-71. PubMed ID: 10606363
    [Abstract] [Full Text] [Related]

  • 15. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
    Jacobsson LT, Turesson C, Gülfe A, Kapetanovic MC, Petersson IF, Saxne T, Geborek P.
    J Rheumatol; 2005 Jul 15; 32(7):1213-8. PubMed ID: 15996054
    [Abstract] [Full Text] [Related]

  • 16. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
    Lacaille D, Guh DP, Abrahamowicz M, Anis AH, Esdaile JM.
    Arthritis Rheum; 2008 Aug 15; 59(8):1074-81. PubMed ID: 18668604
    [Abstract] [Full Text] [Related]

  • 17. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.
    Wolfe F, Caplan L, Michaud K.
    Arthritis Rheum; 2006 Feb 15; 54(2):628-34. PubMed ID: 16447241
    [Abstract] [Full Text] [Related]

  • 18. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study.
    Davis JM, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, Roger VL, Gabriel SE.
    Arthritis Rheum; 2007 Mar 15; 56(3):820-30. PubMed ID: 17330254
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis.
    Bernatsky S, Hudson M, Suissa S.
    Rheumatology (Oxford); 2007 Jul 15; 46(7):1157-60. PubMed ID: 17478469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.